Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06269666 · ClinicalTrials.gov registry record · NA
P200TxE Diseased Eye Image Collection
A NA study of Retinal Disease, sponsored by Optos.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06269666 is a NA study of Retinal Disease that is actively recruiting participants, run by Optos. The registered enrollment target is 100 participants, below the 1,236-participant average among 19 other Retinal Disease trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06269666, a NA study of Retinal Disease, is actively recruiting participants, sponsored by Optos.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective is to collect images on the P200TxE device in diseased eyes.
Conditions Studied
Interventions
- DEVICE P200TxE
Study Locations (1)
Kentucky
- Bennett and Bloom Eye Centers - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-01-31 |
| Est. Completion | 2024-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06269666
The ClinicalTrials.gov registry entry for NCT06269666 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,236-participant average among 19 other Retinal Disease trials with a reported enrollment target (92% lower). The listed sponsor is Optos, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Retinal Disease appearing as the primary indexed condition, and to 1 intervention - of which P200TxE is the first listed.
NCT06269666 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT06269666 about?
NCT06269666 is a clinical study titled "P200TxE Diseased Eye Image Collection". The primary objective is to collect images on the P200TxE device in diseased eyes.
What is the current status of trial NCT06269666?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-01-31. Estimated completion is 2024-12-01.
What conditions does trial NCT06269666 study?
This clinical trial studies the following conditions: Retinal Disease.
What interventions are being tested in trial NCT06269666?
The interventions under investigation include: P200TxE (DEVICE).
Who is sponsoring clinical trial NCT06269666?
This trial is sponsored by Optos, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06269666 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease
RECRUITING · NA
-
Stem Cell Ophthalmology Treatment Study II
RECRUITING · NA
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
RECRUITING
-
Data Gathering for A10900
RECRUITING
-
Inherited Retinal Degenerative Disease Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.